Yan Liu
Affiliations: | 2013-2016 | School of Life Sciences, Xiamen University |
Google:
"Yan Liu"Mean distance: (not calculated yet)
Parents
Sign in to add mentorXianming DENG | grad student | 2013-2016 | School of Life Sciences, Xiamen University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Li Z, Ishida R, Liu Y, et al. (2022) Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffold. European Journal of Medicinal Chemistry. 238: 114433 |
Lu Y, Fan Z, Zhu SJ, et al. (2021) A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC. Embo Molecular Medicine. e14296 |
Ferguson FM, Liu Y, Harshbarger W, et al. (2020) Correction to "Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6-benzo[]pyrimido[5,4-][1,4]diazepin-6-one Scaffold". Journal of Medicinal Chemistry |
Liu Y, Ferguson FM, Li L, et al. (2020) Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. Cell Chemical Biology |
Ferguson FM, Liu Y, Harshbarger W, et al. (2020) Synthesis and structure activity relationships of DCLK1 kinase inhibitors based on a 5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one scaffold. Journal of Medicinal Chemistry |
Ferguson FM, Nabet B, Raghavan S, et al. (2020) Discovery of a selective inhibitor of doublecortin like kinase 1. Nature Chemical Biology |
Liu Y, Qin X, Lu X, et al. (2019) Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model. Canadian Journal of Physiology and Pharmacology. 1-8 |
Wong KK, Liu Y, Li Y, et al. (2017) Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma. Cancer Research |
Li R, Zhao JX, Su Y, et al. (2016) High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial. Medicine. 95: e3968 |
Zhang X, Zhang C, Lin Y, et al. (2016) Nanocomposite Membranes Enhance Bone Regeneration Through Restoring Physiological Electric Microenvironment. Acs Nano |